Jorge Mallea, MD
Pulmonary Disease · Jacksonville, FLNPI 1306825781
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $452,648 of the $457,048 with a category attached, or 99.0%. United Therapeutics Corporation accounts for 99.2% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $253,954, more than ten times the $362 reported in 2019. Among pulmonary disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $10,882 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$453K
- Xvivo Perfusion Inc.$3K
- Pulmonx Corporation$319
- Medela LLC$317
- Terumo BCT, Inc.$33
Across 21 payments — averaging $1678.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- United Therapeutics Corporation$14K
- Gyrus ACMI, Inc.$12K
- Spiration, Inc.$9K
What the payments were for
- Consulting fees$452,64899%
- Travel & lodging$2,8881%
- Food & beverage$1,5120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 29 | $453,257 |
| Xvivo Perfusion Inc. | 8 | $3,122 |
| Pulmonx Corporation | 2 | $319 |
| Medela LLC | 2 | $317 |
| Terumo BCT, Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$457,048 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Jacksonville
- Jennifer FultonJacksonville$665K
- Jose Soto SotoJacksonville$504K
- Abubakr BajwaJacksonville$414K
- Bryan HustaJacksonville$283K
- Sebastian Fernandez-BussyJacksonville$257K
- Peter NassarJacksonville$141K
- Charles BurgerJacksonville$124K
- Daniel WyzanJacksonville$100K
- David Abia TrujilloJacksonville$68K
- Franck RahaghiWeston$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.